Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Immunochemistry Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020

Published by GlobalData Product code 974397
Published Content info 658 Pages
Delivery time: 1-2 business days
Price
Back to Top
Immunochemistry Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020
Published: November 30, 2020 Content info: 658 Pages
Description

GlobalData's Medical Devices sector report, "Immunochemistry Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Immunochemistry Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Immunochemistry Rapid Tests & POC intended generally for rapid diagnosis, with immediate results, through immuno assays. Some of the tests carried out using immunochemistry rapid test include rabies virus test, allergenic food proteins, and enteric infection.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Pancreatic Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Immunochemistry Rapid Tests & POC and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Immunochemistry Rapid Tests & POC under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
Product Code: GDME1037EPD

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Immunochemistry Rapid Tests and POC Overview

3 Products under Development

  • 3.1 Immunochemistry Rapid Tests and POC - Pipeline Products by Stage of Development
  • 3.2 Immunochemistry Rapid Tests and POC - Pipeline Products by Segment
  • 3.3 Immunochemistry Rapid Tests and POC - Pipeline Products by Territory
  • 3.4 Immunochemistry Rapid Tests and POC - Pipeline Products by Regulatory Path
  • 3.5 Immunochemistry Rapid Tests and POC - Pipeline Products by Estimated Approval Date

4 Immunochemistry Rapid Tests and POC - Pipeline Products under Development by Companies

  • 4.1 Immunochemistry Rapid Tests and POC Companies - Pipeline Products by Stage of Development
  • 4.2 Immunochemistry Rapid Tests and POC - Pipeline Products by Stage of Development

5 Immunochemistry Rapid Tests and POC Companies and Product Overview

6 Immunochemistry Rapid Tests and POC - Recent Developments

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

List of Tables

  • Table 1: Immunochemistry Rapid Tests & POC - Pipeline Products by Stage of Development
  • Table 2: Immunochemistry Rapid Tests & POC - Pipeline Products by Segment
  • Table 3: Immunochemistry Rapid Tests & POC - Pipeline Products by Territory
  • Table 4: Immunochemistry Rapid Tests & POC - Pipeline Products by Regulatory Path
  • Table 5: Immunochemistry Rapid Tests & POC - Pipeline Products by Estimated Approval Date
  • Table 6: Immunochemistry Rapid Tests & POC - Ongoing Clinical Trials
  • Table 7: Immunochemistry Rapid Tests & POC Companies - Pipeline Products by Stage of Development
  • Table 8: Immunochemistry Rapid Tests & POC - Pipeline Products by Stage of Development
  • Table 9: 1Drop Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: One Drop Diagnostic Device - Allergy - Product Status
  • Table 11: One Drop Diagnostic Device - Allergy - Product Description
  • Table 12: One Drop Diagnostic Device - Anemia - Product Status
  • Table 13: One Drop Diagnostic Device - Anemia - Product Description
  • Table 14: One Drop Diagnostic Device - Cancer - Product Status
  • Table 15: One Drop Diagnostic Device - Cancer - Product Description
  • Table 16: One Drop Diagnostic Device - Cardiovascular Disease - Product Status
  • Table 17: One Drop Diagnostic Device - Cardiovascular Disease - Product Description
  • Table 18: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: ARCHITECT c4000 System - PCT Assay - Product Status
  • Table 20: ARCHITECT c4000 System - PCT Assay - Product Description
  • Table 21: Abbott Point of Care Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: i-STAT Alinity - Cancer - Product Status
  • Table 23: i-STAT Alinity - Cancer - Product Description
  • Table 24: i-STAT TnI-Nx - Product Status
  • Table 25: i-STAT TnI-Nx - Product Description
  • Table 26: Abionic SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: CRP Based Inflammation Test - Product Status
  • Table 28: CRP Based Inflammation Test - Product Description
  • Table 29: PSP IVD CAPSULE - Product Status
  • Table 30: PSP IVD CAPSULE - Product Description
  • Table 31: Abionic SA - Ongoing Clinical Trials Overview
  • Table 32: PSP IVD CAPSULE - A Multicenter, Prospective, Biomarker-result-blinded Observational Study Evaluating Immunoassay Measurements of Pancreatic Stone Protein Performed on Abionic's abioSCOPE Device with the PSP Assay on ICU Patients at Risk of Sepsis as an Aid in Identifying Sepsis
  • Table 33: PSP IVD CAPSULE - A Study to Establish a Reference Range for abioSCOPE Device with the PSP Assay in a Generally Healthy Adult Population
  • Table 34: Abwiz Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: Kawasaki Disease (KD) Test Kit - Product Status
  • Table 36: Kawasaki Disease (KD) Test Kit - Product Description
  • Table 37: Accel Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: PreeMo Assay - Product Status
  • Table 39: PreeMo Assay - Product Description
  • Table 40: pScreen BNP - Product Status
  • Table 41: pScreen BNP - Product Description
  • Table 42: Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 43: Rapid Diagnostic Test - Sickle Cell Anemia - Product Status
  • Table 44: Rapid Diagnostic Test - Sickle Cell Anemia - Product Description
  • Table 45: Acuamark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 46: Eagle i5 - Product Status
  • Table 47: Eagle i5 - Product Description
  • Table 48: Eagle iSeq - Product Status
  • Table 49: Eagle iSeq - Product Description
  • Table 50: Affinergy LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: Diagnostic Test - Amyotrophic Lateral Sclerosis - Product Status

List of Figures

List of Figures

  • Figure 1: Immunochemistry Rapid Tests & POC - Pipeline Products by Stage of Development
  • Figure 2: Immunochemistry Rapid Tests & POC - Pipeline Products by Segment
  • Figure 3: Immunochemistry Rapid Tests & POC - Pipeline Products by Territory
  • Figure 4: Immunochemistry Rapid Tests & POC - Pipeline Products by Regulatory Path
  • Figure 5: Immunochemistry Rapid Tests & POC - Pipeline Products by Estimated Approval Date
  • Figure 6: Immunochemistry Rapid Tests & POC - Ongoing Clinical Trials
Back to Top